The Zurich Heart House would like to invite you to a special webinar on
How to achieve new lipid goals in high-risk patients? From statins, NPC1L1 transport inhibitors to PCSK9 antibodies
Date: Thursday, March 3rd 2022, 17:00 – 18:30 CET
We are looking forward to meeting you during this webinar.
Christian Mueller, Basel
Isabella Sudano, Zurich
Thomas F. Lüscher, Zurich and London
Chairs in ZHH Studio: Christian Mueller, Basel, Isabella Sudano, Zurich, Thomas F. Lüscher, Zurich and London
|17:00||Introduction||Christian Mueller, Basel|
|17:05||The 2019 ESC/EAS Guidelines and the lipid goals||Francois Mach, Geneva|
|17:20||What we achieved so far: statins and ezetimibe||Thomas F. Lüscher, London|
|17:35||Effectiveness and safety of the PCSK9 inhibitors||Ulf Landmesser, Berlin|
|17:50||Mind the gap: Do we reach the lipid goals in real world?||Thomas Rosemann, Zurich|
|18:25||Key messages||Isabella Sudano, Zurich|
This programme is supported by Amgen.
The scientific programme has not been influenced in any way by its sponsor.